Steven F. Bellon insider trades
Open-market stock purchases and sales by Steven F. Bellon, Chief Scientific Officer at Foghorn Therapeutics Inc, from SEC Form 4 filings since Jan 26, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 30, 2026 | FHTX Foghorn Therapeutics Inc | Bought (not open market) | $1.7M |
Companies traded
- FHTX Foghorn Therapeutics Inc: 1 sale, last Jan 30, 2026